a physician a building location a clinical trial a department
menu
BCM - Baylor College of Medicine

Giving life to possible

Clinical Trials

Safety and Efficacy of LCI699 in Cushing's Disease Patients (H-31940)

This exploratory study is a proof of concept study to determine whether LCI699 can safely reduce the level of urinary free cortisol in patients with Cushing's disease. In addition, this study will evaluate the long term efficacy and safety of LCI699 including an additional 12 week of treatment followed by a 12 month long term optional extension.

For more information: http://clinicaltrials.gov/ct2/show/NCT01331239